Cronos Group Inc (OTCMKTS:PRMCF) is still on an upward trajectory. PRMCF has seen some pullback but the stock is still on the hero path up the charts. A month ago, PRMCF was an unknown trading a little more than $3 and now the stock has cleared the $10 mark with ease.

Granted, part of this rise is about the historic cannabis rush we are seeing across all markets, but PRMCF has created their own fuel here with some strong company moves. The first and most notable is a bought deal that netted them $30 million in funding. When this news hit the wire on the first trading day of the year, it seemed to catapult them toward an inflection point.

Cronos Group Inc (OTCMKTS:PRMCF) trumpets itself as a geographically diversified and vertically integrated cannabis company that operates two wholly-owned Licensed Producers (“LPs”) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) and holds a portfolio of minority investments in other Licensed Producers.

PRMCF formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group was incorporated in January 2013 and is based in Toronto, Canada.

The Company’s flagship LPs, Peace Naturals Project Inc. (Ontario) and Original BC Ltd. (British Columbia), are collectively situated on over 125 acres of agricultural, licensed land.

Cronos Group is focused on building an international iconic brand portfolio, providing patients with personalized care, and creating value for our shareholders.

Find out when $PRMCF stock reaches critical levels. Subscribe to FinanceRegistrar.com Right Now by entering your Email in the box below.

The second driver for PRMCF was news that its shipments of Peace Naturals were about to hit the shelves in Germany. With over 82 million people, Germany is the largest federally legal cannabis market in the world, and Pohl-Boskamp’s, the company PRMCF is working with in Germany, provides Cronos access to patients with insurance coverage for medicinal cannabis.

“This marks a key milestone for Cronos by solidifying the largest international distribution platform in the industry and providing an unprecedented supply of high-quality medical cannabis products to German patients,” said Mike Gorenstein , CEO of Cronos.

This type of deal offers PRMCF international reach and diverses the revenue buckets as the company waits for Canada’s full-scale legalization to ensue. In our minds, this move shows leadership’s strategy to not stay idle in this bull market.

Earning a current market cap value of $1.61B, PRMCF is excellent shape financially and continues to tack on nice deals to their already strong revenue stream. Investor confidence is high here and we believe that this is a stock that must be on your watch list until further notice. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $PRMCF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $PRMCF, either long or short, and we have not been compensated for this article.